Select Publications
Journal articles
2013, 'Association between abdominal obesity and fracture risk: A prospective study', Journal of Clinical Endocrinology and Metabolism, 98, pp. 2478 - 2483, http://dx.doi.org/10.1210/jc.2012-2958
,2013, 'Bariatric surgery, bone loss, obesity and possible mechanisms', Obesity Reviews, 14, pp. 52 - 67, http://dx.doi.org/10.1111/j.1467-789X.2012.01050.x
,2013, 'Excess Mortality Attributable to Hip-Fracture: A Relative Survival Analysis', Bone, 56, pp. 23 - 29, http://dx.doi.org/10.1016/j.bone.2013.05.006
,2013, 'Neuropeptide y is a critical modulator of Leptin's regulation of cortical bone', Journal of Bone and Mineral Research, 28, pp. 886 - 898, http://dx.doi.org/10.1002/jbmr.1786
,2013, 'Neuropeptide Y mediates the short-term hypometabolic effect of estrogen deficiency in mice', International Journal of Obesity, 37, pp. 390 - 398, http://dx.doi.org/10.1038/ijo.2012.71
,2013, 'PP149-SUN THE BERGEN NUTRITIONAL STRATEGY: FOUR QUESTIONS PREDICT MORBIDITY, MORTALITY AND EXPENSES IN A UNIVERSITY HOSPITAL', Clinical Nutrition, 32, pp. S78 - S79, http://dx.doi.org/10.1016/s0261-5614(13)60194-6
,2013, 'Quantitative ultrasound and fracture risk prediction in non-osteoporotic men and women as defined by WHO criteria', Calcified Tissue International, 24, pp. 1015 - 1022, http://dx.doi.org/10.1007/s00198-012-2001-2
,2013, 'The nutritional strategy: Four questions predict morbidity, mortality and health care costs', Clinical Nutrition, http://dx.doi.org/10.1016/j.clnu.2013.09.008
,2013, 'When Is a U-Curve Actually a J-Curve? Is It Really Too Much of a Good Thing?', The Journal of Clinical Endocrinology & Metabolism, 98, pp. 1863 - 1864, http://dx.doi.org/10.1210/jc.2013-1890
,2012, 'Comment on: Cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis', Osteoporosis International, 23, pp. 2063 - 2065, http://dx.doi.org/10.1007/s00198-011-1830-8
,2012, 'In Memoriam: Philip Neil Sambrook', Osteoporosis International, pp. 1 - 2, http://dx.doi.org/10.1007/s00198-012-2010-1
,2012, 'Absolute fracture-risk prediction by a combination of calcaneal quantitative ultrasound and bone mineral density', Calcified Tissue International, 90, pp. 128 - 136, http://dx.doi.org/10.1007/s00223-011-9556-3
,2012, 'Association between beta-blockers and fracture risk: A Bayesian meta-analysis', Bone, 51, pp. 969 - 974, http://dx.doi.org/10.1016/j.bone.2012.07.013
,2012, 'Clinical applications for vitamin D assays: what is known and what is wished for', Clinical Chemistry, 57, pp. 1227 - 1232, http://dx.doi.org/10.1373/clinchem.2010.154997
,2012, 'Genetics and the individualized prediction of fracture', Current Osteoporosis Reports, 10, pp. 236 - 244, http://dx.doi.org/10.1007/s11914-012-0113-4
,2012, 'Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture', Nature Genetics, 44, pp. 491 - 501, http://dx.doi.org/10.1038/ng.2249
,2012, 'Hip fractures in Norway 1999-2008: time trends in total incidence and second hip fracture rates. A NOREPOS study', European Journal of Epidemiology, 27, pp. 807 - 814, http://dx.doi.org/10.1007/s10654-012-9711-9
,2012, 'Important risk factors and attributable risk of vertebral fractures in the population-based Tromso study', BMC Musculoskeletal Disorders, 13, pp. 163, http://dx.doi.org/10.1186/1471-2474-13-163
,2012, 'Increased bone mineral density in Aboriginal and Torres Strait Islander Australians: Impact of body composition differences', Bone, 51, pp. 123 - 130, http://dx.doi.org/10.1016/j.bone.2012.04.011
,2012, 'Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention', Journal of Bone and Mineral Research, 27, pp. 2039 - 2046, http://dx.doi.org/10.1002/jbmr.1698
,2012, 'Osteoporosis in young adults: pathophysiology, diagnosis, and management', Osteoporosis International, 23, pp. 2735 - 2748, http://dx.doi.org/10.1007/s00198-012-2030-x
,2012, 'Prevalence of vertebral fractures in women and men in the population-based Tromsø study', BMC Musculoskeletal Disorders, 13, pp. Article number 3, http://dx.doi.org/10.1186/1471-2474-13-3
,2012, 'Serum level of under-carboxylated osteocalcin and bone mineral density in early menopausal Norwegian women', European Journal of Nutrition, 52, pp. 49 - 55, http://dx.doi.org/10.1007/s00394-011-0285-1
,2012, 'WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk', PLoS Genetics, 8, pp. e1002745, http://dx.doi.org/10.1371/journal.pgen.1002745
,2011, 'Vitamin D and osteoporosis', , pp. 1129 - 1144, http://dx.doi.org/10.1016/B978-0-12-381978-9.10061-7
,2011, 'Prognosis of fracture: Evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram: Rejoinder to comments by Pluskiewicz and Drozdzowska', Osteoporosis International, 22, pp. 2563, http://dx.doi.org/10.1007/s00198-010-1527-4
,2011, 'FOUR-YEAR RESULTS OF A PHASE 2 STUDY OF THE CATHEPSIN K INHIBITOR ODANACATIB IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY: EFFECTS ON BONE MINERAL DENSITY AND BONE TURNOVER MARKERS', OSTEOPOROSIS INTERNATIONAL, 22, pp. S426 - S426, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000309257500009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'Lawrence G. Raisz November 13, 1925-August 25, 2010.', Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 26, pp. 903 - 911, http://dx.doi.org/10.1002/jbmr.368
,2011, '&-Actinin-3 deficiency is associated with reducted bone mass in human and mouse', Bone, 49, pp. 790 - 798, http://dx.doi.org/10.1016/j.bone.2011.07.009
,2011, 'Association between beta-blocker use and fracture risk: The Dubbo Osteoporosis Epidemiology Study', Bone, 48, pp. 451 - 455, http://dx.doi.org/10.1016/j.bone.2010.10.170
,2011, 'Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis', Osteoporosis International, 22, pp. 967 - 982, http://dx.doi.org/10.1007/s00198-010-1424-x
,2011, 'Development of a simple prognostic nomogram for individualising 5-year and 10-year absolute risks of fracture: a population-based prospective study among postmenopausal women', Annals of the Rheumatic Diseases, 70, pp. 92 - 97, http://dx.doi.org/10.1136/ard.2010.131813
,2011, 'Four-year Results of a Phase 2 Study of the Cathepsin K Inhibitor Odanacatib in Postmenopausal Women with Low Bone Mineral Density: Effects on Bone Mineral Density and Bone Turnover Markers', Journal of Clinical Densitometry, 14, pp. 165 - 165, http://dx.doi.org/10.1016/j.jocd.2011.02.042
,2011, 'Genetic profiling and individualized prognosis of fracture', Journal of Bone and Mineral Research, 26, pp. 414 - 419, http://dx.doi.org/10.1002/jbmr.219
,2011, 'Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk', PLOS Genetics, 7, pp. e1001372, http://dx.doi.org/10.1371/journal.pgen.1001372
,2011, 'Independent external validation of nomograms for predicting risk of low-trauma fracture and hip fracture', Canadian Medical Association Journal (CMAJ), 183, pp. E107 - E114, http://dx.doi.org/10.1503/cmaj.100458
,2011, 'Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect', Journal of Bone and Mineral Research, 26, pp. 242 - 251, http://dx.doi.org/10.1002/jbmr.212
,2011, 'Osteoporosis medication and reduced mortality risk in elderly women and men', Journal of Clinical Endocrinology and Metabolism, 96, pp. 1006 - 1014, http://dx.doi.org/10.1210/jc.2010-2730
,2011, 'Risk factors for in-hospital post-hip fracture mortality', Bone, 49, pp. 553 - 558, http://dx.doi.org/10.1016/j.bone.2011.06.002
,2011, 'Vitamin D status and parathyroid hormone in a urban population in Vietnam', Osteoporosis International, 22, pp. 241 - 248, http://dx.doi.org/10.1007/s00198-010-1207-4
,2010, 'Individualized Prognosis of Fracture in Men', , pp. 361 - 373, http://dx.doi.org/10.1016/B978-0-12-374602-3.00029-8
,2010, 'VDR gene polymorphisms on risk of osteoporotic hip fracture in an adult population spanish', Ars Pharmaceutica, 51, pp. 193 - 201
,2010, 'Managing the patient with osteoporosis', Medicine Today, 11
,2010, 'Vitamin D deficiency in adults', Australian Prescriber, 33, pp. 103 - 106, http://dx.doi.org/10.18773/austprescr.2010.053
,2010, 'Clinical fractures cluster in time after initial fracture', Maturitas, 67, pp. 339 - 342, http://dx.doi.org/10.1016/j.maturitas.2010.09.002
,2010, 'Odanacatib in the treatment of postmenopausal women with low bone mineral density: 3-year continued therapy and resolution of effect', Bone, 47, pp. S68 - S68, http://dx.doi.org/10.1016/j.bone.2010.04.132
,2010, 'Odanacatib in the Treatment of Postmenopausal Women with Low Bone Mineral Density: 3-Year Continued Therapy and Resolution of Effect', Journal of Clinical Densitometry, 13, pp. 133 - 133, http://dx.doi.org/10.1016/j.jocd.2010.01.087
,2010, 'Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density', Journal of Bone and Mineral Research, 25, pp. 937 - 947, http://dx.doi.org/10.1359/jbmr.091035
,2010, 'Pharmacogenetics of osteoporosis-related bone fractures: moving towards the harmonization and validation of polymorphism diagnostic tools', Pharmacogenomics, 11, pp. 1287 - 1303, http://dx.doi.org/10.2217/pgs.10.116
,2009, 'Genetics of Osteoporosis', , pp. 213 - 219, http://dx.doi.org/10.1002/9780470623992.ch42
,